Peroxynitrite Inactivates Tissue Plasminogen Activator

Anesthesia and Analgesia

Volumn 98, Issue 5, 2004, Pages 1312-1317

  Nielsen, Vance G ^a   Crow, John P ^d   Zhou, Fen ^a   Parks, Dale A ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PEROXYNITRITE; RECOMBINANT ENZYME; RECOMBINANT HUMAN SUPEROXIDE DISMUTASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; DEVICE; ENZYME ACTIVITY; FIBRINOLYSIS; HUMAN; IN VIVO STUDY; INCUBATION TIME; PHYSIOLOGY; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; THROMBOSIS;

EID: 1942532996     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000111105.38836.F6     Document Type: Article

References (19)

1. Robbie LA, Booth NA, Brown AJ, Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 1996;16:539-45.
2. Labarrere CA, Deng MC. Microvascular prothrombogenicity and transplant coronary artery disease. Transpl Immunol 2002;9:243-9.
3. Feng Y, Hart G. In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions. Cardiovasc Res 1995;30:255-61.
4. Hazell LJ, Arnold L, Flowers D, et al. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996;97:1535-44.
5. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994;375:81-8.
6. Depre C, Havaux X, Renkin J, et al. Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovasc Res 1999;41:465-72.
7. Esaki T, Hayashi T, Muto E, et al. Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide 2000;4:561-71.
8. Pennica D, Holmes WE, Kohr WJ, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983;301:214-21.
9. Meh DA, Mosesson MW, DiOrio JP, et al. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagul Fibrinolysis 2001;12:627-37.
10. Khurana S, Mattson JC, Westley S, et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130:401-11.
11. Hartert H, Schaeder JA. The physical and biologic constants of thromboelastography. Biorheology 1962;1:31-9.
12. Crow JP. Dichlorodihydrofluorescein and dihydrorodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997;1:145-57.
13. Crow JP, Sampson JB, Zhuang Y, et al. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem 1997;69:1936-44.
14. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992;281:419-24.
15. Crow JP. Manganese and iron porphyrins catalyze peroxynitrite decomposition and simultaneously increase nitration and oxidant yield: implications for their use as peroxynitrite scavengers in vivo. Arch Biochem Biophys 1999;371:41-52.
16. Feelisch M, Ostrowski J, Noack E. On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 1989;14(Suppl 11):S13-22.
17. Lupidi G, Angeletti M, Eleuteri AM, et al. Peroxynitrite-mediated oxidation of fibrinogen inhibits clot formation. FEBS Lett 1999;462:236-40.
18. Gole MD, Souza JM, Choi I, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000;278:L961-7.
19. Adam JM, Ettelaie C, Naseem KM, et al. Modification of tissue factor by peroxynitrite influences its procoagulant activity. FEBS Lett 1998;429:347-50.